Edgewise Therapeutics, Inc. (EWTX)
43.68
-2.25
(-4.90%)
USD |
NASDAQ |
Nov 16, 16:00
43.59
-0.09
(-0.21%)
After-Hours: 20:00
Edgewise Therapeutics Total Assets (Quarterly) : 1.780B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.780B |
| June 30, 2026 | 479.69M |
| March 31, 2026 | 518.52M |
| December 31, 2025 | 552.60M |
| September 30, 2025 | 583.47M |
| June 30, 2025 | 613.33M |
| March 31, 2025 | 454.39M |
| December 31, 2024 | 486.82M |
| September 30, 2024 | 511.28M |
| June 30, 2024 | 531.65M |
| March 31, 2024 | 553.81M |
| December 31, 2023 | 340.04M |
| Date | Value |
|---|---|
| September 30, 2023 | 311.36M |
| June 30, 2023 | 330.62M |
| March 31, 2023 | 346.40M |
| December 31, 2022 | 367.10M |
| September 30, 2022 | 377.15M |
| June 30, 2022 | 257.40M |
| March 31, 2022 | 272.74M |
| December 31, 2021 | 285.23M |
| September 30, 2021 | 294.45M |
| June 30, 2021 | 303.49M |
| March 31, 2021 | 311.24M |
| December 31, 2020 | 131.14M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 6.773M |
| CNBX Pharmaceuticals, Inc. | 0.0128M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 607.50M |
| Fulcrum Therapeutics, Inc. | 310.81M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 147.35M |
| Shareholders Equity (Quarterly) | 1.633B |
| Debt to Equity Ratio | 0.0021 |
| Current Ratio | 12.30 |
| Net Debt Paydown Yield | 0.00% |